Cargando…

Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma

BACKGROUND: Minimal residual disease (MRD) measurement is a cornerstone of contemporary acute lymphoblastic leukaemia (ALL) treatment. The presence of immunoglobulin (Ig) and T cell receptor (TCR) gene recombinations in leukaemic clones allows widespread use of patient-specific, DNA-based MRD assays...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subhash, Vinod Vijay, Huang, Libby, Kamili, Alvin, Wong, Marie, Chen, Dan, Venn, Nicola C., Atkinson, Caroline, Mayoh, Chelsea, Venkat, Pooja, Tyrrell, Vanessa, Marshall, Glenn M., Cowley, Mark J., Ekert, Paul G., Norris, Murray D., Haber, Michelle, Henderson, Michelle J., Sutton, Rosemary, Fletcher, Jamie I., Trahair, Toby N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810788/ https://www.ncbi.nlm.nih.gov/pubmed/34471258 http://dx.doi.org/10.1038/s41416-021-01538-z

Ejemplares similares

Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy
por: Kamili, Alvin, et al.
Publicado: (2020)

Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions
por: Venn, Nicola C., et al.
Publicado: (2022)

Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor
por: Nagabushan, Sumanth, et al.
Publicado: (2021)

The RNA‐helicase DDX21 upregulates CEP55 expression and promotes neuroblastoma
por: Putra, Vina, et al.
Publicado: (2021)

DIPG-75. PRECISION MEDICINE FOR PAEDIATRIC HIGH-GRADE DIFFUSE MIDLINE GLIOMAS - RESULTS FROM THE ZERO CHILDHOOD CANCER COMPREHENSIVE PRECISION MEDICINE PROGRAM
por: Khuong-Quang, Dong-Anh, et al.
Publicado: (2020)

Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma
por: Hastings, Jordan F., et al.
Publicado: (2023)

Suppression of the ABCA1 Cholesterol Transporter Impairs the Growth and Migration of Epithelial Ovarian Cancer
por: Gao, Jixuan, et al.
Publicado: (2022)

High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
por: Mayoh, Chelsea, et al.
Publicado: (2023)

Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression
por: Toscan, Cara E., et al.
Publicado: (2020)

ABCC4/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma
por: Huynh, Tony, et al.
Publicado: (2012)

Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia
por: Alruwetei, Abdulmohsen M., et al.
Publicado: (2020)

Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study
por: D’Silva, Arlene M., et al.
Publicado: (2023)

Antagonizing Bcl-2 Family Members Sensitizes Neuroblastoma and Ewing’s Sarcoma to an Inhibitor of Glutamine Metabolism
por: Olsen, Rachelle R., et al.
Publicado: (2015)

Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma
por: Ziegler, David S., et al.
Publicado: (2018)

RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL)
por: Rehn, Jacqueline, et al.
Publicado: (2022)

Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma
por: Gamble, Laura D., et al.
Publicado: (2012)

Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma
por: Terry, Rachael L., et al.
Publicado: (2021)

Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes
por: Ajuyah, Pamela, et al.
Publicado: (2023)

DIPG-15. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA
por: Khan, Aaminah, et al.
Publicado: (2020)

RARE-02. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA
por: Khan, Aaminah, et al.
Publicado: (2021)

Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer
por: Tsoli, Maria, et al.
Publicado: (2018)

JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma
por: Wong, Matthew, et al.
Publicado: (2019)

Prediction of reproductive performance of ewes based on the early production data, ewe birth rank, dam age, and dam birth rank
por: Vlahek, Ivan, et al.
Publicado: (2023)

β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma
por: Pasquier, E, et al.
Publicado: (2013)

Risk factors for intellectual and educational sequelae of cranial irradiation in childhood acute lymphoblastic leukaemia.
por: Smibert, E., et al.
Publicado: (1996)

An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
por: Nagy, Zsuzsanna, et al.
Publicado: (2021)

An unexpected role for caspase-2 in neuroblastoma
por: Dorstyn, L, et al.
Publicado: (2014)

A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma
por: Cheung, Belamy B., et al.
Publicado: (2021)

Treatment of childhood lymphocytic leukaemia with high white-cell counts.
por: Ekert, H., et al.
Publicado: (1978)

Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation
por: Le Grand, Marion, et al.
Publicado: (2020)

Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma.
por: Gilbert, J., et al.
Publicado: (1997)

Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia
por: Bhadri, Vivek A, et al.
Publicado: (2011)

Recurrent SPECC1L–NTRK fusions in pediatric sarcoma and brain tumors
por: Khuong-Quang, Dong-Anh, et al.
Publicado: (2020)

In vitro and in vivo drug screens of tumor cells identify novel therapies for high‐risk child cancer
por: Lau, Loretta M S, et al.
Publicado: (2021)

Presenting features of neuroblastoma with spinal canal invasion. A prospective study of the International Society of Pediatric Oncology Europe - Neuroblastoma (SIOPEN)
por: Sorrentino, Stefania, et al.
Publicado: (2022)

Hospitalizations in Australian children with neuroblastoma: A population‐based study
por: Signorelli, C., et al.
Publicado: (2023)

Birth characteristics and risk of Ewing sarcoma
por: Wiemels, Joseph L., et al.
Publicado: (2023)

Lack of correlation between MYCN expression and the Warburg effect in neuroblastoma cell lines
por: Smith, Danielle J, et al.
Publicado: (2008)

MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma
por: Lau, Diana T., et al.
Publicado: (2015)

Advances in CAR T cell immunotherapy for paediatric brain tumours
por: Rao, Padmashree, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f9ns2d2nah488qjfdgil1v0q5m